China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited (2877.HK) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for China Shineway Pharmaceutical Group Limited (HKSE:2877.HK).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer2877.HK Technical Analysis Summary
China Shineway Pharmaceutical Group Limited stock currently shows a bearish trend, weighed down by selling pressure and weak momentum.
Overall, China Shineway Pharmaceutical Group Limited remains neutral, with indicators showing mixed momentum.
RSI (14): 29.08
Stochastic %K: 5.48
Williams %R: -89.92
Rate of Change (ROC): -10.22
Takeaway:China Shineway Pharmaceutical Group Limited shows oversold momentum, with rebound potential building.
MACD: -0.31
ADX: 33.78
ATR (14): 0.29
CCI (14): -109.26
Takeaway:China Shineway Pharmaceutical Group Limited shows weakening trend signals, with bearish pressure building.
Takeaway:China Shineway Pharmaceutical Group Limited trades closer to support, showing weaker momentum within bands.
Takeaway:China Shineway Pharmaceutical Group Limited trades near the lower channel, signaling strong support and possible rebound.
Overall Takeaway:2877.HK shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:China Shineway Pharmaceutical Group Limited shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.